Advertisement

Topics

Review of bovine brucellosis surveillance in Europe in 2015.

07:00 EST 1st December 2018 | BioPortfolio

Summary of "Review of bovine brucellosis surveillance in Europe in 2015."

Bovine brucellosis is a major zoonosis and is responsible for significant reproductive disorders and production losses in cattle. Surveillance and control are regulated at the European level with specific conditions to obtain and maintain the officially free status, which facilitates access to export markets. These European standards allow for harmonisation in brucellosis surveillance and diagnosis while leaving some flexibility to countries in the choice of measures to meet the desired objectives. This study reviews the bovine brucellosis surveillancesystems currently in place across the European continent, according to countries' brucellosis status, based on a survey addressed to brucellosis diagnosis expertsin the National Reference Laboratory of each country. Experts were asked toprovide synthesised surveillance data and to describe technical conditions andscreening tests carried out for the surveillance of abortions, serological testing inherds, movement controls and any other surveillance components in 2015. Results were obtained for 34 out of 37 countries (92%). Surveillance systems included abortion surveillance (34 countries), routine herd screening (28 countries), movement testing (14 countries), routine testing at bull stations (9 countries),and screening tests at slaughterhouses (4 countries). The review highlighted variability in technical conditions and screening tests among countries. These results are discussed with regard to the European Union regulations, disease risks and epidemiological situations, with the aim of improving surveillance efficacy and efficiency.

Affiliation

Journal Details

This article was published in the following journal.

Name: Revue scientifique et technique (International Office of Epizootics)
ISSN: 0253-1933
Pages: 805-821

Links

DeepDyve research library

PubMed Articles [15989 Associated PubMed Articles listed on BioPortfolio]

Characterization and evolution of countries affected by bovine brucellosis (1996 - 2014).

This paper describes the global distribution and temporal evolution of bovine brucellosis due to Brucella abortus during a 19-year period (1996 - 2014) using the information officially reported to the...

Brucellosis seroprevalence in dairy cattle in China during 2008-2018: a systematic review and meta-analysis.

Brucellosis remains one of the most common zoonotic diseases globally with more than a half million human cases reported annually. The Brucella reservoir associated with livestock brucellosis poses a ...

A systematic review and meta-analysis of the prevalence of osteoarticular brucellosis.

Infection of bones and joints remains one of the most commonly described complications of brucellosis in humans and is predominantly reported in all ages and sexes in high-risk regions, such as the Mi...

Human brucellosis caused by raw dairy products: A review on the occurrence, major risk factors and prevention.

Despite considerable efforts made to address the issue of brucellosis worldwide, its prevalence in dairy products remains difficult to estimate and represents an important public health issue in many ...

Fluorescence polarization assay: Diagnostic evaluation for porcine brucellosis.

Brucellosis in pigs, caused by the bacterium Brucella suis, is an important zoonotic infection. In the present study, fluorescence polarization assay (FPA) was standardized and compared with indirect ...

Clinical Trials [3387 Associated Clinical Trials listed on BioPortfolio]

Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD

This is a Phase II, randomized, double-blind, placebo-controlled study designed to investigate whether hyperimmune bovine milk IgG products specific for CsbD and CS17, protect subjects aga...

Influence of Bovine Milk Consumption on Hormonal Profile in Males

50 men will be recruited to this study. Participants will be asked to ingest commercially available bovine milk. Hormonal profile will be analyzed before and after consumption.

Lactoferrin Infant Feeding Trial - LIFT_Canada

This is a multicentre, phase III, 2-arm, masked randomized controlled trial. The primary hypothesis is that oral bovine lactoferrin (bLF), through its antimicrobial, antioxidant and anti-i...

Sinus Lift With Newly Forming Bone and Inorganic Bovine Bone

The aim of this study is to evaluate the efficacy of newly forming bone graft (NFB) in the gain of bone volume in sinus lift procedures. For that, it will be compared the tomographic bone ...

In-market Utilisation of Liraglutide Used for Weight Management in Europe: a Retrospective Medical Record Review Study

This study is conducted in Europe. The aim of this study is to investigate usage of liraglutide for weight management in clinical practice.

Medical and Biotech [MESH] Definitions

A disease of cattle caused by bacteria of the genus BRUCELLA leading to abortion in late pregnancy. BRUCELLA ABORTUS is the primary infective agent.

Review of the medical necessity of hospital or other health facility admissions, upon or within a short time following an admission, and periodic review of services provided during the course of treatment.

The type species of DELTARETROVIRUS that causes a form of bovine lymphosarcoma (ENZOOTIC BOVINE LEUKOSIS) or persistent lymphocytosis.

Process that is gone through in order for a device to receive approval by a government regulatory agency. This includes any required preclinical or clinical testing, review, submission, and evaluation of the applications and test results, and post-marketing surveillance. It is not restricted to FDA.

Formal programs for assessing drug prescription against some standard. Drug utilization review may consider clinical appropriateness, cost effectiveness, and, in some cases, outcomes. Review is usually retrospective, but some analysis may be done before drugs are dispensed (as in computer systems which advise physicians when prescriptions are entered). Drug utilization review is mandated for Medicaid programs beginning in 1993.

Advertisement
Quick Search
Advertisement
Advertisement

 


DeepDyve research library

Searches Linking to this Article